← Open Payments lookup

KEVIN CARNEY: Open Payments

NPI 1871874685 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,746 in 60 payments from 12 companies in 2025. Trend: 2023 $14,053 · 2024 $8,800 · 2025 $8,746

Honoraria: $3,610Speaker / faculty: $2,374Food & beverage: $2,102Travel & lodging: $660
CompanyPaymentsAmount
Verona Pharma, Inc.19$7,309
AstraZeneca Pharmaceuticals LP8$441
Viatris Specialty LLC11$301
GlaxoSmithKline, LLC.9$233
Astellas Pharma US Inc3$185
Pulmonx Corporation3$101
Amgen Inc.2$52
United Therapeutics Corporation1$37
AtriCure, Inc.1$27
Boehringer Ingelheim Pharmaceuticals, Inc.1$24

Products named: Ohtuvayre, YUPELRI, NUCALA, Cresemba, BREZTRI, FASENRA, CHARTIS CATHETER, TEZSPIRE.

Industry payments across PA — which companies pay providers there.